Compare LAC & BVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | LAC | BVS |
|---|---|---|
| Founded | 2023 | 2011 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Metal Mining | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Basic Materials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.0B | 892.4M |
| IPO Year | 2023 | 2016 |
| Metric | LAC | BVS |
|---|---|---|
| Price | $2.23 | $13.63 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 12 | 5 |
| Target Price | $5.56 | ★ $17.60 |
| AVG Volume (30 Days) | ★ 7.4M | 405.6K |
| Earning Date | 11-13-2026 | 11-03-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 163.46 |
| EPS | N/A | ★ 0.52 |
| Revenue | N/A | ★ $568,087,000.00 |
| Revenue This Year | N/A | $6.46 |
| Revenue Next Year | N/A | $6.74 |
| P/E Ratio | ★ N/A | $26.02 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $2.22 | $6.47 |
| 52 Week High | $10.52 | $15.89 |
| Indicator | LAC | BVS |
|---|---|---|
| Relative Strength Index (RSI) | 21.21 | 53.21 |
| Support Level | N/A | $13.44 |
| Resistance Level | $3.31 | $14.33 |
| Average True Range (ATR) | 0.09 | 0.47 |
| MACD | -0.04 | -0.00 |
| Stochastic Oscillator | 5.62 | 66.88 |
Lithium Americas Corp is a Canadian-based resource and materials company focused on developing, building and operating lithium deposits and chemical processing facilities. The company also holds investments in Green Technology Metals Limited (GT1) and Ascend Elements, Inc. (Ascend Elements), and exploration properties in the U.S. and Canada. The company's flagship asset is Thacker Pass, a sedimentary-based lithium deposit located in the McDermitt Caldera in Humboldt County, in northern Nevada (Thacker Pass or the Project). The company operates in only one operating segment and one geographical segment.
Bioventus Inc is a medical device company focused on developing and commercializing products to relieve pain and address musculoskeletal conditions. The company operates through two reporting segments, U.S. and International, and its product portfolio is organized into three main business areas: Pain Treatments, Surgical Solutions, and Restorative Therapies, offering products such as hyaluronic acid injections for osteoarthritis, peripheral nerve stimulation devices, bone graft substitutes, and ultrasound-based fracture healing therapies.